China SXT Pharmaceuticals, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
SXTC Nasdaq 2830 www.sxtchina.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for China SXT Pharmaceuticals, Inc.

China SXT Pharmaceuticals, Inc. Announces Share Consolidation - Aug 5th, 2026 7:00 am
Univest Securities, LLC Announces Closing of $9 Million Registered Direct Offering for its Client China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) - Jul 24th, 2026 3:30 pm
China SXT Pharmaceuticals Inc. Announces $9 Million Registered Direct Offering - Jul 23rd, 2026 6:45 am
China SXT Pharmaceuticals, Inc. Announces Share Re-classification - Mar 23rd, 2026 7:00 am
CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC INITIATIVE TO APPLY AI TECHNOLOGY ACROSS THE TCM SUPPLY CHAIN - Jan 15th, 2026 7:00 am
Univest Securities, LLC Announces Closing of $10 Million Registered Direct Offering for its Client China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) - Jan 13th, 2026 3:00 pm
China SXT Pharmaceuticals Inc. Announces $10 Million Registered Direct Offering - Jan 9th, 2026 12:50 pm
CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC AI INSIGHTS INITIATIVE TO OPTIMIZE TRADITIONAL CHINESE MEDICINE PORTFOLIO, ENHANCE MARKET ANALYSIS AND EXPLORE AI-SUPPORTED CLINIC DEPLOYMENT - Jan 8th, 2026 7:20 am